XTL Biopharmaceuticals Ltd.
Patents, Design & Utilities

Last updated:

List of all XTL Biopharmaceuticals Ltd. patents 1 in total

Status Patent
Application
Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING 0.25 MG DOSE OF SYNTHETIC HUMAN PEPTIDES FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS External link
Filling date: 7 Sep 2025 Issue date: 29 Oct 2020

Showing 1 to 1 of 1 patents.